Please try another search
For the nine months ended 31 December 2021, LeanLife Health Inc revenues was not reported. Net loss decreased 5% to C$2.1M. Lower net loss reflects Share-based compensation decrease of 69% to C$199K (expense), Consulting fees decrease of 48% to C$274K (expense), Engineering and testing decrease of 81% to C$29K (expense). Basic Earnings per Share excluding Extraordinary Items remained flat at -C$0.01.
Period Ending: | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
---|---|---|---|---|
Total Revenue | 0 | 0 | 0 | 0 |
Gross Profit | ||||
Operating Income | -0.72 | -0.71 | -0.77 | -1.35 |
Net Income | -0.67 | -0.7 | -0.74 | -1.45 |
Period Ending: | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
---|---|---|---|---|
Total Assets | 1.25 | 1.26 | 1.19 | 1.29 |
Total Liabilities | 2.11 | 1.87 | 1.3 | 1.06 |
Total Equity | -0.86 | -0.61 | -0.11 | 0.23 |
Period Ending: | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | -0.77 | -0.83 | -0.41 | -1.21 |
Cash From Investing Activities | -0 | -0 | -0 | -0.15 |
Cash From Financing Activities | 0.52 | 0.58 | 0.18 | 1.63 |
Net Change in Cash | -0.26 | -0.26 | -0.23 | 0.26 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review